Nanogrow, a nanobody drug developer, named Best Startup of VDS 2026
Venture Map 19 firms1 outlet ShowHide
In this story 19
- Airway ShieldStart-up
- eWearStart-up
- Find NidoStart-up
- HeuristikStart-up
- LetMeParkStart-up
- MentelemStart-up
- Mitiga SolutionsStart-up
- Pack2EarthStart-up
- RobopedicsStart-up
- Sycai MedicalStart-up
- Tesai CareStart-up
- The Gravity WaveStart-up
- TrueColdStart-up
- Armilar Venture PartnersVC
- BcombinatorVC
- Lumo LabsVC
- Plug and Play Tech CenterVC
- Rumbo VenturesVC
- VentureFriendsVC
Coverage 1
- EmprendedoresOriginal on Emprendedores (opens in a new tab) 23 Oct
The story so far, in brief; the legwork, and the full article, stay with the original outlet.
Nanogrow has been named Best Startup of VDS 2026, ahead of 1,560 start-ups from 87 countries that entered this year's competition. It develops biological medicines built on nanobodies, for both animals and humans, delivered through local routes such as creams or inhalers. Plug and Play led the evaluation, and a jury of investors from firms including Armilar, Antler and Indico Capital picked the winner from 25 finalists drawn from 10 countries.
The prize is $2,000 in Miro credits and €150,000 in Microsoft Azure credits, which is a large amount of cloud for a company whose products go in inhalers. It also brings access to VDS's content programme, introductions to investors and a place in Santander X 100. Days earlier, Nanogrow was named one of Navarra's five most innovative start-ups in the TOP 101 Spain Up Nation awards.
Prisma Clima, Mitiga Solutions and Mentelem took the other three awards.